NeuroBo Pharmaceuticals, Inc. NRBO
Set alert
2.36 0.00 0.00%
At close · Nov 27
2.36 Day range 2.36
52-week range unavailable
- Open
- 0.00
- Prev close
- 2.36
- Mkt cap
- 20.33M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.36
- High
- 2.36
- Forward P/E
- -1.39
- Beta
- -0.28
- Short ratio
- 0.87
- Inst. own
- 12.71%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 7, 2024
- 50-d avg
- 2.59
- 200-d avg
- 3.63
- 1y target
- 26.67
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 26.67 +1029.9% upside
Now 2.36
- Target (low)
- 10.00
- Target (mean)
- 26.67
- Target (high)
- 48.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
- 2 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 8, 2024 | Maxim Group | Initiated | — | Buy |